|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
See Header: Thrombosis due to other internal prosth dev/grft
ICD-10 (CM) Code and Descriptor
|
T85.868A |
Thrombosis due to other internal prosthetic devices, implants and grafts, initial encounter
|
T85868A utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 38.66%
|
13.88%
|
13.71%
|
6.50%
|
5.98%
|
5.80%
|
4.75%
|
4.04%
|
0.70%
|
1.41%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for T85.868A*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85610
|
PROTHROMBIN TIME |
123
|
123
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
122
|
123
|
|
J1644
|
INJ HEPARIN SODIUM PER 1000U |
71
|
541
|
|
J3010
|
FENTANYL CITRATE INJECTION |
66
|
119
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
57
|
57
|
|
C1769
|
GUIDE WIRE |
53
|
136
|
|
80048
|
METABOLIC PANEL TOTAL CA |
53
|
54
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
53
|
3,810
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
49
|
127
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
39
|
1,323
|
|
C1725
|
CATH, TRANSLUMIN NON-LASER |
38
|
89
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
35
|
135
|
|
85730
|
THROMBOPLASTIN TIME PARTIAL |
35
|
40
|
|
C1894
|
INTRO/SHEATH, NON-LASER |
34
|
84
|
|
J2405
|
ONDANSETRON HCL INJECTION |
33
|
158
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
33
|
58
|
|
80053
|
COMPREHEN METABOLIC PANEL |
32
|
32
|
|
C1757
|
CATH, THROMBECTOMY/EMBOLECT |
31
|
44
|
|
85027
|
COMPLETE CBC AUTOMATED |
29
|
29
|
|
82962
|
GLUCOSE BLOOD TEST |
27
|
49
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
T85.868A related to the following DRG Codes:
919-921
|
